Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse

巡逻单核细胞在 HIV/药物滥用期间脑血管修复中的作用

基本信息

项目摘要

Abstract (30 lines or less) HIV-associated neurocognitive disorders (HAND) remain a concern in the US and worldwide for the nearly 40 million people living with HIV. One of the hallmark features of HAND pathogenesis is the infiltration of immune cells and viral replication in the brain. This process occurs in part due to a loss of blood-brain barrier (BBB) integrity, which results in hyperpermeability and increased immune cell extravasation. Additionally, it is well established that drugs of abuse can exacerbate HAND by augmenting blood-brain barrier (BBB) dysfunction and neuroinflammation. The mechanisms that govern BBB resilience, or lack thereof, and recovery during HIV/substance abuse remain understudied. This proposal is based on the central premise that understanding these mechanisms could identify means to speed BBB recovery, attenuate immune cell infiltration and ultimately slow the progression of HAND. We are focused on a subclass of immune cells, non-classical monocytes or patrolling monocytes, that have been identified for their unique functions in vascular maintenance and homeostasis. Patrolling monocytes have been shown to survey the luminal endothelial surface, scavenge debris and initiate vascular repair. These processes are clearly positive effects that aid in the preservation and recovery of the vasculature. However, the functions of these specialized cells have not been studied in the context of substance abuse or HIV. We will test the central hypothesis that cocaine impairs patrolling monocyte function and repair of the BBB. Additionally, we will also investigate the innovative concept that the cerebral vascular endothelium communicates the need for vascular repair through extracellular vesicles. We propose a multilateral approach that utilizes in vivo models, advanced in vitro microfluidic modeling of the BBB, and analysis of clinical samples to understand the role and function of patrolling monocytes in the context of HIV/substance abuse. Importantly, our use of advanced in vitro microfluidic modeling of the BBB with primary human cells presents the opportunity to study endothelial-immune interactions in a way that more closely mimics the human in vivo environment. Overall, the studies encompassed in this proposal will advance current knowledge regarding patrolling monocyte function, cerebral endothelial-immune interactions, and establish a novel mechanism by which drugs of abuse contributes to HAND.
摘要(不超过30行) 艾滋病毒相关的神经认知障碍(手)在美国和世界范围内仍然是一个令人担忧的问题,近40 一百万艾滋病毒携带者。手部发病的一个显著特征是免疫细胞的渗透。 细胞和病毒在大脑中的复制。这一过程的部分原因是血脑屏障(BBB)的丧失。 完整性,这会导致高渗透性和免疫细胞外渗增加。另外,它是好的 证实滥用药物可通过增加血脑屏障(BBB)功能而加重手部疾病 和神经炎。管理血脑屏障复原力或缺乏复原力的机制,以及在 艾滋病毒/药物滥用问题仍未得到充分研究。这项提议是基于这样一个中心前提,即理解 这些机制可以确定加速血脑屏障恢复、减弱免疫细胞渗透和 最终减缓手部的进展。我们关注的是免疫细胞的一个子类,非经典的 单核细胞或巡逻单核细胞,已被鉴定为在血管中的独特功能 维持和动态平衡。巡视单核细胞已被证明可以检测管腔内皮细胞 表面,清除碎屑,启动血管修复。这些过程显然是积极的影响,有助于 血管系统的保存和恢复。然而,这些专门细胞的功能并没有 在药物滥用或艾滋病毒的背景下进行了研究。我们将检验可卡因损害的中心假说 巡逻单核细胞功能与血脑屏障的修复。此外,我们还将研究创新的概念 脑血管内皮细胞通过细胞外传递血管修复的需要 水泡。我们提出了一种利用体内模型、先进的体外微流控技术的多边方法 建立血脑屏障模型,并对临床标本进行分析,以了解巡逻的角色和功能 单核细胞在艾滋病毒/药物滥用方面的作用。重要的是,我们使用了先进的体外微流控技术 用原代人类细胞模拟血脑屏障为研究内皮免疫提供了机会 以一种更接近于人体体内环境的方式进行交互。总体而言,这些研究 这份提案中包含的内容将促进当前关于巡逻单核细胞功能、大脑 内皮-免疫相互作用,并建立一种新的机制,滥用药物有助于 手。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Allison Michelle Andrews其他文献

Allison Michelle Andrews的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Allison Michelle Andrews', 18)}}的其他基金

Innovative In-Situ Imaging Techniques for the Visualization of CNS associated HIV reservoirs in the Context of Substance Abuse
创新的原位成像技术,用于在药物滥用情况下可视化中枢神经系统相关的艾滋病毒储存库
  • 批准号:
    10682957
  • 财政年份:
    2023
  • 资助金额:
    $ 14.99万
  • 项目类别:
HIV and Cocaine Drive Bone-Marrow Blood (BMB) Barrier Dysfunction and Altered Hematopoietic Stem Cell (HSC) Differentiation Leading to Cardiovascular Disease
HIV 和可卡因导致骨髓血液 (BMB) 屏障功能障碍和造血干细胞 (HSC) 分化改变,导致心血管疾病
  • 批准号:
    10469745
  • 财政年份:
    2022
  • 资助金额:
    $ 14.99万
  • 项目类别:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
巡逻单核细胞在 HIV/药物滥用期间脑血管修复中的作用
  • 批准号:
    10080722
  • 财政年份:
    2019
  • 资助金额:
    $ 14.99万
  • 项目类别:
Role of Patrolling Monocytes in Cerebral Vascular Repair during HIV/Substance Abuse
巡逻单核细胞在 HIV/药物滥用期间脑血管修复中的作用
  • 批准号:
    10557168
  • 财政年份:
    2019
  • 资助金额:
    $ 14.99万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 14.99万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 14.99万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 14.99万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 14.99万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 14.99万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 14.99万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 14.99万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 14.99万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 14.99万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 14.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了